1. Home
  2. FMC vs AORT Comparison

FMC vs AORT Comparison

Compare FMC & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FMC Corporation

FMC

FMC Corporation

HOLD

Current Price

$17.84

Market Cap

2.0B

Sector

Industrials

ML Signal

HOLD

Logo Artivion Inc.

AORT

Artivion Inc.

HOLD

Current Price

$36.02

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FMC
AORT
Founded
1910
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.7B
IPO Year
1994
1996

Fundamental Metrics

Financial Performance
Metric
FMC
AORT
Price
$17.84
$36.02
Analyst Decision
Hold
Strong Buy
Analyst Count
13
5
Target Price
$17.75
$48.76
AVG Volume (30 Days)
3.5M
367.6K
Earning Date
04-29-2026
05-04-2026
Dividend Yield
1.81%
N/A
EPS Growth
N/A
165.62
EPS
N/A
0.21
Revenue
$4,727,800,000.00
$298,836,000.00
Revenue This Year
$8.18
$14.20
Revenue Next Year
$4.16
$11.17
P/E Ratio
N/A
$167.55
Revenue Growth
N/A
18.01
52 Week Low
$12.17
$22.22
52 Week High
$44.77
$48.25

Technical Indicators

Market Signals
Indicator
FMC
AORT
Relative Strength Index (RSI) 67.63 48.69
Support Level $12.88 $34.60
Resistance Level $44.47 $38.42
Average True Range (ATR) 0.85 1.43
MACD 0.31 0.07
Stochastic Oscillator 95.48 72.41

Price Performance

Historical Comparison
FMC
AORT

About FMC FMC Corporation

FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.

About AORT Artivion Inc.

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

Share on Social Networks: